Abdón G. Ruiz
Director/Board Member at Genomas, Inc.
Abdón G. Ruiz active positions
| Companies | Position | Start | End |
|---|---|---|---|
Genomas, Inc.
 Genomas, Inc. Medical/Nursing ServicesHealth Services Genomas, Inc. operates as a biomedical company. It develops revolutionary PhyzioType Systems for DNA-guided management and prescription of drugs to treat mental illness, pain, heart disease, and diabetes. The firm’s products include HILOmet PhyzioType System, PIMS PhyzioType, SINM PhyzioType, and GLIM PhyzioType systems. The company was founded by Gualberto Ruaño in 2004 and is headquartered in Hartford, CT. | Director/Board Member | - | - |
Career history of Abdón G. Ruiz
Former positions of Abdón G. Ruiz
| Companies | Position | Start | End |
|---|---|---|---|
| Federal Reserve Bank of Boston | Corporate Officer/Principal | - | - |
Miradero Capital Partners, Inc.
 Miradero Capital Partners, Inc. Investment ManagersFinance Miradero Capital Partners, Inc (Miradero Capital Partners) is a private equity firm founded by Zoilo Méndez and Abdón G. Ruiz in 2001. The firm is headquartered in San Juan, Puerto Rico. | Founder | 31/12/2000 | - |
| Private Equity Investor | 12/01/2012 | - |
Training of Abdón G. Ruiz
| Massachusetts Institute of Technology | Undergraduate Degree |
| Boston University | Masters Business Admin |
Statistics
International
| United States | 5 |
Operational
| Founder | 1 |
| Private Equity Investor | 1 |
| Director/Board Member | 1 |
Sectoral
| Finance | 3 |
| Health Services | 2 |
| Government | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Miradero Capital Partners, Inc.
Miradero Capital Partners, Inc. Investment ManagersFinance Miradero Capital Partners, Inc (Miradero Capital Partners) is a private equity firm founded by Zoilo Méndez and Abdón G. Ruiz in 2001. The firm is headquartered in San Juan, Puerto Rico. | Finance |
Genomas, Inc.
Genomas, Inc. Medical/Nursing ServicesHealth Services Genomas, Inc. operates as a biomedical company. It develops revolutionary PhyzioType Systems for DNA-guided management and prescription of drugs to treat mental illness, pain, heart disease, and diabetes. The firm’s products include HILOmet PhyzioType System, PIMS PhyzioType, SINM PhyzioType, and GLIM PhyzioType systems. The company was founded by Gualberto Ruaño in 2004 and is headquartered in Hartford, CT. | Health Services |
| Federal Reserve Bank of Boston | Government |
- Stock Market
- Insiders
- Abdón G. Ruiz
- Experience
